Concepedia

Balázs Szalay

BS

25

Publications

784

Citations

17

H-Index

2009

Active since

Affiliations

Semmelweis University(Current)

University of Szeged

Hungarian Academy of Sciences

University of Pecs

University of Debrecen

Balázs Szalay is an author at Semmelweis University specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

2009–2023

25

Publications

25

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

K Gecse, Barbara D. Lovász, Klaudia Farkas et al. · Journal of Crohn s and Colitis · 2015 · 182 citations · Full text

T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy

Sonja Dulic, Zsófia Vásárhelyi, Florentina Sava et al. · Mediators of Inflammation · 2017 · 69 citations · Full text

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

Lóránt Gönczi, K Gecse, Zsuzsanna Végh et al. · Inflammatory Bowel Diseases · 2017 · 56 citations · Full text

The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study

Balázs Szalay, Barna Vásárhelyi, Áron Cseh et al. · Clinical Rheumatology · 2013 · 43 citations

, , +14

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ákos Iliás, K Szántó, Lóránt Gönczi et al. · Clinical Gastroenterology and Hepatology · 2019 · 34 citations · Full text

, , +5

Rows per page

1–5 of 25